TABLE A2.
Proxy measure of infectiousness | Shape parameter (ki)a | Mean (1/ri) (days)a |
---|---|---|
Latent period (days) | ||
Skin lesionsb | 38.0 (10.9, 103.3) | 7.6 (6.6, 8.9) |
Viremia (PCR) | ||
Clinically affected animals | 3.8 (2.0, 6.9) | 5.4 (4.2, 7.1) |
Subclinical animals | 3.9 (1.4, 9.1) | 5.5 (3.9, 8.3) |
Infectious period (days) | ||
Skin biopsy samplesb | 11.4 (2.8, 38.2) | 23.6 (17.1, 38.0) |
Viremia (PCR) | ||
Clinically affected animals | 3.4 (1.3, 7.6) | 19.0 (13.7, 30.4) |
Subclinical animals | 2.5 (0.9, 5.7) | 15.2 (10.2, 27.2) |
Posterior median (95% credible interval).
Clinically affected animals only.